Vaxart, Inc.
VXRT· OTC
Filed Sep 27, 2013 · 10-K · 89 days after period end · 0001437749-13-012393
| Metric | Q4 2013 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $9.30M | $2.09M | — |
| Net Income | -$6.50M | -$7.06M | — |
| EPS Diluted | -$0.23 | -$0.31 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Sep 27, 2013 · 89 d after period end